Literature DB >> 29187496

Mucinous Cystic Neoplasms Lined by Abundant Mucinous Epithelium Frequently Involve KRAS Mutations and Malignant Progression.

Hideki Shibata1,2,3, Nobuyuki Ohike2, Tomoko Norose2, Tomohide Isobe2, Reika Suzuki2, Hideyuki Imai2, Akira Shiokawa2, Takeshi Aoki3, Masahiko Murakami3, Hiroki Mizukami4, Jun-Ichi Tanaka4, Masafumi Takimoto5.   

Abstract

BACKGROUND: Pancreatic and hepatic mucinous cyst neoplasms (MCNs) have a malignant potential, but indolent MCNs are not uncommon.
MATERIALS AND METHODS: The pathological and genetic characteristics of resected MCNs (n=15) categorized by the amount of mucin of the lining epithelium were investigated.
RESULTS: MCNs were divided into two groups: (i) a rich (r)-MCN group (n=6), in which more than half of the epithelium was lined by abundant mucinous epithelium; and (ii) a poor (p)-MCN group (n=9), which consisted of the remaining cases. Three patients in the r-MCN group showed invasive carcinoma or high-grade dysplasia, whereas all patients in the p-MCN group showed low-grade dysplasia. Mutations of Kirsten rat sarcoma viral oncogene homolog (KRAS) were more frequent in the r-MCN group (83%) (p-MCN; 11%, p<0.05).
CONCLUSION: Mucinous MCNs more frequently have KRAS mutations and higher risk of malignant progression. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  KRAS mutation; Mucinous cystic neoplasm; liver; malignant progression; mucinous epithelium; pancreas

Mesh:

Substances:

Year:  2017        PMID: 29187496     DOI: 10.21873/anticanres.12178

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Serial EUS-Guided FNA for the Surveillance of Pancreatic Cysts: A Study of Long-Term Performance of Tumor Markers.

Authors:  Mahmoud A Rahal; John M DeWitt; Harsh Patel; C Max Schmidt; Eugene P Ceppa; Rachel E Simpson; Stuart Sherman; Mohammad Al-Haddad
Journal:  Dig Dis Sci       Date:  2022-02-28       Impact factor: 3.487

2.  Clinicopathological and Molecular Differences Between Gastric-type Mucinous Carcinoma and Usual-type Endocervical Adenocarcinoma of the Uterine Cervix.

Authors:  Hera Jung; Go Eun Bae; Hye Min Kim; Hyun-Soo Kim
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

3.  Mucinous Cystic Neoplasm of the Cystic Duct: A Rare Location of a Rare Entity.

Authors:  Nicholas J Caldwell; Ilham Farhat; Sarag Boukhar
Journal:  Cureus       Date:  2021-04-09

4.  RNF43 as a predictor of malignant transformation of pancreatic mucinous cystic neoplasm.

Authors:  Kukiko Sakihama; Yutaka Koga; Takeo Yamamoto; Yuki Shimada; Yutaka Yamada; Jun Kawata; Koji Shindo; Masafumi Nakamura; Yoshinao Oda
Journal:  Virchows Arch       Date:  2022-01-23       Impact factor: 4.064

5.  The role of mucin cell-free DNA detection as a new marker for the study of acellular pseudomyxoma peritonei of appendicular origin by liquid biopsy.

Authors:  Damián García-Olmo; Susana Olmedillas-López; Delia Cortés-Guiral; Pedro Villarejo; Irene López Rojo; Héctor Guadalajara; Soledad García Gómez-Heras; Mariano García-Arranz
Journal:  Ther Adv Med Oncol       Date:  2020-06-24       Impact factor: 8.168

6.  Exploring and validating the clinical risk factors for pancreatic cancer in chronic pancreatitis patients using electronic medical records datasets: three cohorts comprising 2,960 patients.

Authors:  Xin Zhao; Ren Lang; Zhigang Zhang; Weiling Zhao; Zhiwei Ji; Hua Tan; Xiaobo Zhou
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.